The malignant cells usually express the B-cell-specific surface markers CD19 and CD20, as well as low-to-intermediate levels of common acute lymphoblastic leukaemia (ALL) antigen (CD10/CALLA) [20]. This evidence concerns the gene MME and acute lymphoblastic leukemia.